BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 16289692)

  • 1. The genetics of generalized vitiligo and associated autoimmune diseases.
    Spritz RA
    J Dermatol Sci; 2006 Jan; 41(1):3-10. PubMed ID: 16289692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetics of generalized vitiligo.
    Spritz RA
    Curr Dir Autoimmun; 2008; 10():244-57. PubMed ID: 18460890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetics of generalized vitiligo and associated autoimmune diseases.
    Spritz RA
    Pigment Cell Res; 2007 Aug; 20(4):271-8. PubMed ID: 17630960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiopathology and genetics of vitiligo.
    Passeron T; Ortonne JP
    J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PTPN22-1858C>T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population.
    Laberge GS; Birlea SA; Fain PR; Spritz RA
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):206-8. PubMed ID: 18426414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NALP1 in vitiligo-associated multiple autoimmune disease.
    Jin Y; Mailloux CM; Gowan K; Riccardi SL; LaBerge G; Bennett DC; Fain PR; Spritz RA
    N Engl J Med; 2007 Mar; 356(12):1216-25. PubMed ID: 17377159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes.
    Shajil EM; Chatterjee S; Agrawal D; Bagchi T; Begum R
    Indian J Exp Biol; 2006 Jul; 44(7):526-39. PubMed ID: 16872041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic association of NALP1 with generalized vitiligo in Jordanian Arabs.
    Alkhateeb A; Qarqaz F
    Arch Dermatol Res; 2010 Oct; 302(8):631-4. PubMed ID: 20574744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity as an aetiological factor in vitiligo.
    Rezaei N; Gavalas NG; Weetman AP; Kemp EH
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):865-76. PubMed ID: 17658994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients.
    Zhang Z; Xu SX; Zhang FY; Yin XY; Yang S; Xiao FL; Du WH; Wang JF; Lv YM; Tang HY; Zhang XJ
    Arch Dermatol Res; 2009 Feb; 301(2):167-73. PubMed ID: 18839195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases.
    Amerio P; Di Rollo D; Carbone A; Auriemma M; Marra ME; De Remigis P; Feliciani C; Tracanna M; Tulli A
    Eur J Dermatol; 2010; 20(3):354-8. PubMed ID: 20395193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional profiling of melanocytes from patients with vitiligo vulgaris.
    Strömberg S; Björklund MG; Asplund A; Rimini R; Lundeberg J; Nilsson P; Pontén F; Olsson MJ
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):162-71. PubMed ID: 18426409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in the genetics of generalized vitiligo.
    Spritz RA
    J Genet Genomics; 2011 Jul; 38(7):271-8. PubMed ID: 21777851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The autoimmune regulator gene (AIRE) is strongly associated with vitiligo.
    Tazi-Ahnini R; McDonagh AJ; Wengraf DA; Lovewell TR; Vasilopoulos Y; Messenger AG; Cork MJ; Gawkrodger DJ
    Br J Dermatol; 2008 Sep; 159(3):591-6. PubMed ID: 18616774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff.
    Boissy RE; Spritz RA
    Exp Dermatol; 2009 Jul; 18(7):583-5. PubMed ID: 19320739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetics of vitiligo].
    Lacour JP; Ortonne JP
    Ann Dermatol Venereol; 1995; 122(4):167-71. PubMed ID: 8526411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants.
    Jin Y; Andersen G; Yorgov D; Ferrara TM; Ben S; Brownson KM; Holland PJ; Birlea SA; Siebert J; Hartmann A; Lienert A; van Geel N; Lambert J; Luiten RM; Wolkerstorfer A; Wietze van der Veen JP; Bennett DC; Taïeb A; Ezzedine K; Kemp EH; Gawkrodger DJ; Weetman AP; Kõks S; Prans E; Kingo K; Karelson M; Wallace MR; McCormack WT; Overbeck A; Moretti S; Colucci R; Picardo M; Silverberg NB; Olsson M; Valle Y; Korobko I; Böhm M; Lim HW; Hamzavi I; Zhou L; Mi QS; Fain PR; Santorico SA; Spritz RA
    Nat Genet; 2016 Nov; 48(11):1418-1424. PubMed ID: 27723757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo.
    Kemp EH; Gavalas NG; Gawkrodger DJ; Weetman AP
    Autoimmun Rev; 2007 Jan; 6(3):138-42. PubMed ID: 17289548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are pediatric autoimmune diseases primarily genetic diseases?
    Shaw EA; Stevens AM
    Curr Opin Rheumatol; 2008 Sep; 20(5):589-94. PubMed ID: 18698183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of genetic association of promoter and structural variants of mannan-binding lectin (MBL2) gene with susceptibility to generalized vitiligo.
    Dwivedi M; Gupta K; Gulla KC; Laddha NC; Hajela K; Begum R
    Br J Dermatol; 2009 Jul; 161(1):63-9. PubMed ID: 19416237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.